190 results
Page 3 of 10
8-K
EX-99.1
wmz7uycyvtv4s
25 Feb 21
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:04pm
8-K
EX-99.1
gn3rc
3 Feb 21
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
8:36am
424B5
bsaafy0wc7k3e4o6j9xu
13 Oct 20
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
9pfj iud8y9mg8aod
15 Sep 20
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
12:00am
S-3ASR
EX-4.2
qm074fzesmlf
8 Jul 20
Automatic shelf registration
8:50am
S-3ASR
yl9zedvk c1s9q7o1x
8 Jul 20
Automatic shelf registration
8:50am
S-3ASR
EX-1.2
0m45u6lzz kiq3e
8 Jul 20
Automatic shelf registration
8:50am
S-8
EX-10.2
fs6lfsjge1 rggzmtwx
7 Jul 20
Registration of securities for employees
4:20pm
S-8
EX-10.1
mbbur 87p5khc8t3
7 Jul 20
Registration of securities for employees
4:20pm
8-K
EX-10.1
scsjjiygfstk1ui8a
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm
424B5
zwoxzwanzm 2fetqt
2 Mar 20
Prospectus supplement for primary offering
11:44am